1.
Blauvelt A, Iversen L, McBride S, Gooderham M, Staubach P, Yamauchi P, Staelens F, Vanoorden V, White K, Gisondi P. Bimekizumab versus secukinumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Results from the multicenter, randomized, double-blinded phase 3b BE RADIANT trial. J of Skin [Internet]. 2021Nov.5 [cited 2022Aug.8];5(6):s53. Available from: https://jofskin.org/index.php/skin/article/view/1404